Figure 1:
Figure 1:. Predicted probabilities from our 2-gene signature (SLC25A3 and SCARB1) for patient samples in chronic phase (class 0) and blast phase (class 1).

Predicted probabilities from our 2-gene signature (SLC25A3 and SCARB1) for patient samples in chronic phase (class 0) and blast phase (class 1).

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal